T1	Participants 25 96	early positron emission tomography-negative stage I/II Hodgkin lymphoma
T2	Participants 311 366	patients with clinical stage I/II Hodgkin lymphoma (HL)
T3	Participants 867 946	Patients age 15 to 70 years with untreated clinical stage I/II HL were eligible
T4	Participants 1279 1315	The analysis included 1,137 patients
